Stefan Prendergast

Stefan Prendergast is a Senior Analyst at RTW Investments, LP, based in New York, NY, where he focuses on identifying and evaluating investment opportunities within the life sciences sector. In his current role, he conducts in-depth research and analysis of biotechnology and healthcare companies, supporting the firm's portfolio management and investment decision-making activities.

Prior to becoming Senior Analyst, Stefan advanced from Associate to Analyst at RTW Investments, developing expertise in biotech venture and public market investments. His work has contributed to RTW's strategy of investing across the full lifecycle of life sciences companies, spanning therapeutics, medical devices, and related healthcare innovations.

Stefan holds a Bachelor of Science in Biology from the University of Notre Dame and a Master of Science in Biochemistry and Molecular Biology from Johns Hopkins Bloomberg School of Public Health. His scientific education underpins his ability to assess complex biopharmaceutical assets and clinical-stage platforms, making him a valuable contributor to RTW’s focus on transformative healthcare investments.